Zurcher Kantonalbank (Zurich Cantonalbank) Opti Nose, Inc. Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$32.8 Billion
Q3 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 28, 2020	SELL	$3.58 - $7.44 $25,972 - $53,977	-7,255 Closed	0 $0
Q1 2020 May 06, 2020	BUY	$3.49 - $9.2 $16,322 - $43,028	4,677 Added 181.42%	7,255 $33,000
Q4 2019 Jan 21, 2020	SELL	$6.27 - $11.41 $29,569 - $53,809	-4,716 Reduced 64.66%	2,578 $24,000
Q4 2018 Jan 25, 2019	BUY	$5.84 - $11.92 $42,596 - $86,944	7,294 New	7,294 $45,000

Others Institutions Holding OPTN

# of Institutions

Shares Held

88.3M

Call Options Held

Put Options Held

Mvm Partners, LLC Boston, MA

14.6M
Shares

$7.45 Million
10.4% of portfolio
Nantahala Capital Management, LLC New Canaan, CT

14.4M
Shares

$7.32 Million
0.57% of portfolio
Great Point Partners LLC Greenwich, CT

12.9M
Shares

$6.56 Million
3.98% of portfolio
Stonepine Capital Management, LLC Bend, OR

5.69M
Shares

$2.9 Million
2.41% of portfolio
Kingdon Capital Management, L.L.C. New York, NY

5.6M
Shares

$2.86 Million
0.45% of portfolio

View Full List

About OptiNose, Inc.

Ticker OPTN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 83,277,504
Market Cap $42.5M
Description
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...

More about OPTN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account